Investor Overview

Precision Therapeutics (NASDAQ: AIPT) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, through its Skyline Medical division.

Skyline Medical Inc. has a fully automated, patented, and FDA cleared surgical fluid disposal device-the STREAMWAY System-that virtually eliminates operating room workers’ exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment.

Today’s manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. Skyline Medical Inc.'s STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids, which results in:

  • Reducing overhead costs to hospitals and surgical centers
  • Improving their Occupational Safety and Health Administration (OSHA) and other regulatory compliance
  • Enhancing the efficiency of the operating room and thereby making surgeries more profitable

Skyline Medical Inc.'s STREAMWAY System is eco-friendly as it addresses the numerous bloody, potentially disease infected canisters that go into U.S. landfills every year. These tainted canisters—which are generally made of plastic—can take centuries to biodegrade, but with installations of the STREAMWAY System, the number of these canisters can be significantly reduced.

Crystal Research Executive Informational Overview